Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
Full article >>
Wednesday, May 6, 2009
New universal breast cancer marker predicts recurrence and clinical outcome
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment